tert-Butyl 4-hydroxy-1H-pyrazole-1-carboxylate, 97%, 5g

(S)-3-Bromo-piperidine-1-carboxylic acid tert-butyl ester, 95.0%, 500mg

(1R,4S)-1-Methyl-4-(prop-1-en-2-yl)cyclohex-2-enol, 95.0%, 1g

H-D-Leu-OBzl.TosOH, 98%, 25g

N-Ethyl-p-toluidine>98.0%(GC)(T)25mL

N-(3-Bromo-4-chlorophenyl)acetamide, 95%, 1g

(S)-[4-(Pyridin-4-yl)-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-e]azepine-2,6-diyl]bis[bis[4-(tert-butyl)phenyl]methanol]>85.0%(HPLC)50mg

Lithium Hexafluorophosphate>97.0%(T)25g

7-Bromo-1H-indazole-3-carbaldehyde, 95.0%, 1g

Ethyl 5-hydroxy-2-methyl-1-benzofuran-3-carboxylate, 98+%, 500mg

Methyl 3,5-di-tert-butylbenzoate, 98%, 250mg

Ethyl 6-(trifluoromethyl)nicotinate, 95.0%, 25g

OZANIMOD, 95%, 50mg